RxDoctor Payments Data

Frank Rutigliano

Colon & Rectal Surgery · Lexington, KYNPI 1477916484

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,226 of the $7,270 with a category attached, or 71.9%. 33 manufacturers reported payments, led by Intuitive Surgical at 29.7% of the total. Reporting peaked in 2022 at $2,663 and has fallen 52.5% since, to $1,265 in 2025.

$7,270in general payments, 2019–2025

Across 253 payments — averaging $28.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Johnson & Johnson$1K
  • AbbVie$679
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$621
  • Ferring Pharmaceuticals Inc.$373
  • Takeda Pharmaceuticals U.S.A., Inc.$294
  • plus $2K from 27 others

What the payments were for

  • Travel & lodging$1,04414%
  • Food & beverage$5,22672%
  • Education$1,00014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,270 in reported general payments places this provider in the 65th percentile of 28 colon & rectal surgery providers in Kentucky.

See all colon & rectal surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$104,608
Medicare patients
197
Services billed
647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine13$4,217
Colestipol Hcl34$3,491
Budesonide EcBudesonide15$868
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates12$771
Pyridostigmine Bromide13$755
Neomycin Sulfate52$294
Oxycodone Hcl53$234
Ondansetron OdtOndansetron13$217
Metronidazole59$214
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl12$173
Methocarbamol25$165
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$101
Gabapentin13$50
Pregabalin11$44
Tramadol Hcl16$34

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →